← Leaderboards
John Fraser Wright
Stanford University
$447,530
Attributed
$447,530
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $250.8K · FY2022–23$500K$375K$250K$125K$0
'22
'23
Funding mix
By agency
NIH$447,530 · 1
By mechanism
R21$447,530 · 1
Top collaborators
No co-investigators on record.
Most similar at Stanford University
Same institution · by research overlap
- Peter Sarnow$27,278,753
- Mark A Kay$46,920,488
- Utkan Demirci$14,678,583
- Karla Kirkegaard$16,259,244
- Sunnie Thompson$5,411,274
Others in their field
Other Rising Stars on “Cytotoxic Cd8 T Cells”
- Nathan Schuldt · University Of Minnesota$2,999,774
- Alphonsus Ng · University Of Utah$2,758,753
- Eileen Mary O'Reilly · Sloan-Kettering Inst Can Research$2,300,843
- Megan K Ruhland · Oregon Health & Science University$2,265,578
- Hua Wang · University Of Illinois At Urbana-Champaign$2,229,562
- Eva Billerbeck · Albert Einstein College Of Medicine$2,227,294
Research focus
Cytotoxic Cd8 T CellsAdeno-Associated Viral VectorAnabolismAdverse OutcomeAffinity ChromatographyBindingBiological ModelsBisulfiteAntibodiesCellsCellular TransductionCesium ChlorideClinical DataClinical DevelopmentClinical ResearchClinical TrialsCodon NucleotidesComparativeCapsidCpg DinucleotideCross ReactivityCytokineCytosineCytotoxic T-Lymphocytes
Grant awards (2)
Novel AAV vector generation methods to prevent immunogenic unmethylated CpGs that trigger efficacy-limiting CTLs in human gene therapy$250,780
R21 · FY2023 · NS · contact PI
Novel AAV vector generation methods to prevent immunogenic unmethylated CpGs that trigger efficacy-limiting CTLs in human gene therapy$196,750
R21 · FY2022 · NS · contact PI